News | March 1, 2019
Genome editing company Precision proposes $100M IPO
Read More
News | January 16, 2019
Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
Read More
Press Release | January 4, 2019
Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets
Read More
News | January 3, 2019
Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809
Read More
